Article: Medicis to Inamed: either reject Allergan offer or pay $90M fee.

Medicis to Inamed: either reject Allergan offer or pay $90M fee

A Medical Device Daily Staff Report

The current attempt by aesthetic product manufacturers to spread their wings across a spectrum ranging from creams to injectables to breast implants continues with additional twists and turns.

Medicis Pharmaceutial (Scottsdale, Arizona) yesterday said that it has formally given notice to breast implant maker Inamed (Santa Barbara, California) that it recommend to Inamed stockholders rejection of the exchange offer made by Botox manufacturer Allergan (Irvine, California).

Inamed last March agreed to be acquired by Medicis for cash and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!